Evidence map›Paper›PMID 37587072›Full record

ArticleZhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences2023

Inhibitory effects of simeprevir on

Yingjia Li, Chaoni Cai, Zixin Liu, Xichang Tang, Lin Qu, Yuan Wu, Pingyun Wu, Yao Duan, Pengfei She

Open access · greenAbstract read
In one paragraph

Article in Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. [Distribution and Antibiotic Resistance Analysis of Ocular Bacterial Pathogens at a Tertiary Hospital From 2012 to 2021].Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yingjia LiDepartment of Laboratory Medicine, Third Xiangya Hospital, Central South University, Changsha 410013. lyj1260731@126.com.
Chaoni CaiDepartment of Laboratory Medicine, Third Xiangya Hospital, Central South University, Changsha 410013.
Zixin LiuDepartment of Laboratory Medicine, Third Xiangya Hospital, Central South University, Changsha 410013.
Xichang TangDepartment of Laboratory Medicine, Third Xiangya Hospital, Central South University, Changsha 410013.
Lin QuDepartment of Laboratory Medicine, Third Xiangya Hospital, Central South University, Changsha 410013.
Yuan WuDepartment of Laboratory Medicine, Third Xiangya Hospital, Central South University, Changsha 410013.
Pingyun WuDepartment of Laboratory Medicine, Third Xiangya Hospital, Central South University, Changsha 410013.
Yao DuanDepartment of Laboratory Medicine, Third Xiangya Hospital, Central South University, Changsha 410013.
Pengfei SheDepartment of Laboratory Medicine, Third Xiangya Hospital, Central South University, Changsha 410013. shepengfei_xy@csu.edu.cn.
Central South University · CN

Funding

the Natural Science Foundation of Hunan Province 2021JJ40944
6 · The paper itself

Abstract

objectives

methodsThe micro-dilution assay was used to determine the minimal inhibitory concentration (MIC) and minimal bactericidal concentration (MBC) of simeprevir against

resultsSimeprevir showed significant antimicrobial effects against

conclusionsSimeprevir shows antimicrobial effect and anti-biofilm activities against

Indexed as

Cross InfectionSimeprevirAnti-Bacterial AgentsAntiviral AgentsGentamicinsHumansAnti-Bacterial AgentsAntiviral AgentsGentamicinsSimeprevirbiofilmdrug repurposingsimeprevirStaphylococcus epidermidissynergistic effect

Identifiers

PMID37587072
PMCPMC10930433
OpenAlexW4385898639

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.